No results for ‘’
Senores Pharmaceuticals Ltd
NSE: SENORES BSE: 544319
₹1290
(11.14%)
Wed, 24 Jun 2026, 02:43 am
Market Cap (in Cr)5946.67
PE Ratio49.33
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2017
- The company was originally incorporated as Senores Pharmaceuticals Private Limited.
2021
- Incorporated a wholly owned subsidiary, Senores Pharmaceuticals Inc, in the US.
- Entered into a new segment of API with the acquisition of Ratnagene Lifescience Private Limited.
2022
- Started the domestic business with the launch of critical care injectables.
2023
- Changed the company name to Senores Pharmaceuticals Limited upon conversion to a public limited company.
- Received approval from the central government for the name change.
- Obtained a fresh certificate of incorporation reflecting the name change.
2024
- Launched first CMO product in the US with Jubilant Cadista.